There are no clearly-established risk factors for multiple myeloma and it is possible that a combination of factors interact to cause the disease. Thus, there is no method for preventing multiple myeloma.
Myeloma is a condition in which plasma cells become cancerous. It is sometimes referred to as plasma cell dyscrasia or plasma cell myeloma, and most commonly as multiple myeloma (MM). Multiple myeloma is the most common form found in patients.
Yes, multiple myeloma may involve lymph nodes though it usually starts in the bone marrow. I have seen multiple myeloma in lymph nodes and in liver. I am an autopsy pathologist.
myeloma.org (international myeloma foundation) themmrf.org (multiple myeloma research foundation) lls.org (leukemia and lymphoma society) All of these organizations can refer you to myeloma specialists and give more information about treatment.
Myeloma is a condition in which plasma cells become cancerous. It is sometimes referred to as plasma cell dyscrasia or plasma cell myeloma, and most commonly as multiple myeloma (MM). Multiple myeloma is the most common form found in patients.
No.
no
i think smoldering multiple myeloma means that the patient's plasma cells have vacuolated red cytoplasm that looks like cells on fire.
Multiple myeloma is a disease in which malignant plasma cells spread through the bone marrow and hard outer portions of the large bones of the body. These myeloma cells may form tumors called plasmacytomas.
Neil S. Harris has written: 'Multiple myeloma and related serum protein disorders' -- subject(s): Electrophoresis, Myeloma Proteins, Analysis, Blood Proteins, Blood Protein Electrophoresis, Multiple Myeloma, Blood
Lenalidomine is an oral cancer drug also known as Revlimid. It is used to treat all stages of multiple myeloma. It works in multiple ways to slow or kill myeloma cells.
Multiple myeloma has common symptoms such as kidney failure, bone damages and fractures, Anemia-related fatigue, and a high level of calcium in the blood stream.